Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This target is a **long non-coding RNA (lncRNA)** transcribed antisense to the *ALOX12B* gene. It does not encode a protein but may participate in the regulation of the ALOX12B gene through an antisense-sense RNA duplex mechanism. The functional significance of this lncRNA remains largely uncharacterized, although similar antisense lncRNAs have been implicated in regulating gene expression post-transcriptionally or epigenetically[1][3][5]. There are no reports of this transcript itself acting as a drug target, biomarker, or disease gene, though such non-coding RNAs can play important regulatory roles in specific tissues or disease contexts. If structured information is required, there are currently no established drug interactions, therapeutic roles, or validated biomarker uses for this specific transcript, and its functional characterization is incomplete. However, it is correctly annotated as a genomic regulatory element with a likely role in modulating the expression of its sense counterpart, ALOX12B.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel transcript, antisense to ALOX12B (ENSG00000214999).